Accessibility Menu
Universe Pharmaceuticals Inc logo

Universe Pharmaceuticals Inc

(NASDAQ) UPC

Current Price$12.15
Market Cap$1.87M
Since IPO (2021)-100%
5 Year-100%
1 Year-22%
1 Month+4%

Universe Pharmaceuticals Inc Financials at a Glance

Market Cap

$1.87M

Revenue (TTM)

$40.88M

Net Income (TTM)

-$12.40M

EPS (TTM)

-$10.13

P/E Ratio

-0.29

Dividend

$0.00

Beta (Volatility)

0.03 (Low)

Price

$12.15

Volume

47,599,117.486

Open

$17.17

Previous Close

$2.96

Daily Range

$10.51 - $17.96

52-Week Range

$2.00 - $17.96

Estimated Earnings Date

Apr 22, 2026

UPC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Universe Pharmaceuticals Inc

Industry

Pharmaceuticals

Employees

216

CEO

Gang Lai

Headquarters

Ji'An, 343100, CN

UPC Financials

Key Financial Metrics (TTM)

Gross Margin

35.28%

Operating Margin

-16.33%

Net Income Margin

-20.56%

Return on Equity

-6.60%

Return on Capital

-4.46%

Return on Assets

-5.30%

Earnings Yield

-3.45%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.87M

Shares Outstanding

631.80K

Volume

47.60M

Avg. Volume

400.46K

Financials (TTM)

Gross Profit

$12.37M

Operating Income

-$10.94M

EBITDA

-$10.28M

Operating Cash Flow

-$14.56M

Capital Expenditure

-$629.86K

Free Cash Flow

-$15.19M

Cash & ST Invst.

$33.59M

Total Debt

$9.26M

Universe Pharmaceuticals Inc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$8.71M

-37.1%

Gross Profit

$3.14M

-22.8%

Gross Margin

36.03%

N/A

Market Cap

$1.87M

N/A

Market Cap/Employee

$8.31K

N/A

Employees

225

N/A

Net Income

-$387.30K

+92.9%

EBITDA

-$36.21K

+99.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$33.59M

+81.5%

Total Debt

$9.26M

+68.8%

Accounts Receivable

$13.19M

+22.9%

Inventory

$2.19M

-34.4%

Long Term Debt

$0.00

N/A

Short Term Debt

$9.26M

+68.8%

Return on Assets

-5.30%

N/A

Return on Invested Capital

-5.19%

N/A

Free Cash Flow

-$7.78M

-111.3%

Operating Cash Flow

-$7.61M

-109.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SHPHShuttle Pharmaceuticals Holdings, Inc.
$3.33-17.16%
NCELNewcelX Ltd.
$3.65+0.27%
ELABPMGC Holdings Inc.
$1.25+9.21%
WINTWindtree Therapeutics, Inc.
$0.02+25.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CMCSAComcast
$24.65+0.06%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$38.59-0.07%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.35+0.15%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.53-0.03%

Questions About UPC

What is the current price of Universe Pharmaceuticals Inc?

Universe Pharmaceuticals Inc is trading at $11.40 per share.

What is the 52-week range for Universe Pharmaceuticals Inc?

Over the past 52 weeks, Universe Pharmaceuticals Inc has traded between $2.00 and $17.96.

How much debt does Universe Pharmaceuticals Inc have?

As of the most recent reporting period, Universe Pharmaceuticals Inc reported total debt of $9.26M.

How much cash does Universe Pharmaceuticals Inc have on hand?

Universe Pharmaceuticals Inc reported $33.59M in cash and cash equivalents in its most recent financial results.

What is Universe Pharmaceuticals Inc’s dividend yield?

Universe Pharmaceuticals Inc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.